Poslední aktualizace :
19/11/2024
Kurarimimetikas   Suxamethonium chloride  
Įpurškimas
Tirpalų stabilumas Mišinių stabilumas Stabilumą lemiantys veiksniai Suderinamumas Leidimo būdai Bibliografija pdf
   Cheminė sandara  

Prekinis pavadinimas   Prekinis pavadinimas     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Actirelax Argentina
Anectine Airija, Didžioji Britanija, Ispanija, Jungtinės Amerikos Valstijos, Jungtiniai Arabų Emyratai, Meksikas
Celocurin Švedija
Celocurine Belgija, Prancūzija
Chlorsucillin Lenkija
Cholsuxinyl Egiptas
Cloruro de succinilcolina Argentina
Cloruro de suxametonio Peru
Curacit Norvegija
Distensil Peru
Entubate Indija
Ethicoline Malaizija
Fosfitone Argentina, Venesuela
Lycitrope Graikija
Lysthenon Austrija, Jungtiniai Arabų Emyratai, Rumunija, Saudo Arabija, Šveicarija, Vokietija
Midarine Italija, Saudo Arabija, Šveicarija
Mioflex Ispanija, Portugalija
Miokolin Iranas
Myoplegine Belgija, Liuksemburgas
Myotenlis Italija
Pantolax Vokietija
Quelicin Kolumbija
Succi Argentina
Succinilcholina Argentina
Succinilcholina cloruro Peru
Succinolin Šveicarija
Succinyl Liuksemburgas
Succinylcholine Iranas, Kanada, Vokietija
Succyl Iranas
Sukolin Suomija
Suxamethonium Airija, Australija, Didžioji Britanija, Iranas, Malaizija, Naujojoje Zelandijoje
Suxametonio cloruro Čilė, Peru
Suxim Peru
Uxicolin Kolumbija, Meksikas
Bibliografija   Įpurškimas   Bibliografija : Suxamethonium chloride  
tipas leidinys
45 Žurnalas Schmutz CW, Mühlbach SF.
Stability of succinylcholine chloride injection.
Am J Hosp Pharm 1991 ; 48: 501-506.
300 Žurnalas Trissel LA, Gilbert DL, Martinez JF.
Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1287-1292.
319 Žurnalas Hadzija BW, Lubarsky DA.
Compatibility of etomidate, thiopental sodium, and propofol injections with drugs commonly administered during induction of anesthesia.
Am J Health-Syst Pharm 1995 ; 52: 997-999.
667 Žurnalas Pramar YV, Moniz D, Hobbs D.
Chemical stability and adsorption of succinylcholine chloride injections in disposable plastic syringes.
J Clin Pharm Ther 1994 ; 19: 195-198.
1050 Žurnalas Boehm JJ, Dutton DM, Poust RI.
Shelf life of unrefrigerated succinylcholine chloride injection.
Am J Hosp Pharm 1984 ; 41: 300-302.
1721 Žurnalas Trissel LA, Williams KY, Baker MB.
Compatibility screening of Hextend during simulated Y-site administration with other drugs.
Int J Pharm Compound 2001 ; 5: 69-72.
1755 Žurnalas Storms ML, Stewart JT, Warren FW.
Stability of succinylcholine chloride injection at ambient temperature and 4°C in polypropylene syringes.
Int J Pharm Compound 2003 ; 7: 68-70.
2215 Žurnalas Boehm J.J, Poust R.I.
Hydrolysis of succinylcholine chloride in pH range 3.0 to 4.5.
Chem Pharm Bull 1984 ; 32, 3: 1113-1119.
2227 Žurnalas Trusley C, Ben M, Kupiec TC, Trissel LA.
Compatibility and stability of palonosetron hydrochloride with four neuromuscular blocking agents during simulated Y-site administration.
Int J Pharm Compound 2008 ; 12, 2: 156-160.
2360 Žurnalas Roy J.J, Boismenu D, Mamer O.A, Nguyen B.T, Forest J.M, Hildgen P.
Room temperature stability of injectable succinylcholine dichloride.
Int J Pharm Compound 2008 ; 12, 1: 83-85.
3373 Žurnalas Khan S, Stannard N, Greijn J.
Precipitation of thiopental with muscle relaxants: a potential hazard.
J R Soc Med Sh Rep 2011 ; 2: 58.
3631 Laboratorija Suxamethonium (Suxamethonium Aguettant®) - Résumé des caractéristiques du produit
Aguettant 2016
3932 Laboratorija Hydroxocobalamine (Cyanokit®) - Résumé des caractéristiques du produit
Serb Laboratoire 2015
4274 Žurnalas Beck W, Kabiche S, Balde I-B, Carret S, Fontan J-E, Cisternino S, Schlatter J.
Stability of suxamethonium in pharmaceutical solution for injection by validated stability-indicating chromatographic method.
J Clin Anesth 2016 ; 35: 551-559.
4528 Žurnalas Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N.
Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration.
Int J Pharm Compound 2021 ;25,1:52-61

  Mentions Légales